MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Identifying and Managing Spasticity in Neurological Shoulder Dysfunction

D. Hoad, S. Ashford, G. Bavikatte, R. Farrell, A. Robertson, J. Wissel (Coventry, United Kingdom)

Meeting: 2024 International Congress

Abstract Number: 1511

Keywords: Botulinum toxin: Clinical applications: spasticity, Pain, Spasticity: Treatment

Category: Spasticity

Objective: To understand this discrepancy between diagnosis and treatment of spasticity in neurological shoulder dysfunction, we formed an expert panel to establish consensus and provide practical guidance to ensure that people with arm spasticity are assessed for shoulder involvement and that clinicians are confident to treat them.

Background: Shoulder involvement is common in arm spasticity following acquired brain injury.1 In a real-world study of post-stroke arm spasticity management, 56% of patients had shoulder spasticity and 32% received first-line treatment (botulinum toxin).2

Method: The consensus panel comprised six spasticity experts, with a cumulative experience of >100 years. Experts were interviewed individually to understand how they assess people with arm spasticity for shoulder involvement. Responses were discussed and 100% consensus was reached on recommendations during a face-to-face meeting in March 2023.

Results: Recommendations were grouped into three categories: Posture, Purposeful activity and Pain (PPP; ‘the 3 Ps’). Posture of the arm, shoulder and trunk should be observed, considering published shoulder spasticity patterns. Activity (active and passive use of the arm) should be assessed through asking the patient/carer about limitations confirmed by physical examination. Pain is common in shoulder spasticity and should be discussed and rated by the patient at rest, at night and on movement.

Conclusion: Discussion of the problems identified by the patient, supported by examination, should lead to goal setting prior to intervention. These recommendations will support clinicians in identifying spasticity in shoulder impairment associated with stroke and other neurological conditions.

References: 1. Hefter, et al. Int J Rehabil Res. 2012.
2. Turner-Stokes, et al. BMJ Open. 2013.

To cite this abstract in AMA style:

D. Hoad, S. Ashford, G. Bavikatte, R. Farrell, A. Robertson, J. Wissel. Identifying and Managing Spasticity in Neurological Shoulder Dysfunction [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/identifying-and-managing-spasticity-in-neurological-shoulder-dysfunction/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/identifying-and-managing-spasticity-in-neurological-shoulder-dysfunction/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley